http://hdl.handle.net/1893/1273
Appears in Collections: | Faculty of Health Sciences and Sport Journal Articles |
Peer Review Status: | Refereed |
Title: | Complementary and alternative medicine use in patients with haematological malignancies in Europe |
Author(s): | Molassiotis, Alexander Margulies, Anita Fernandez-Ortega, Paz Pud, Dorit Panteli, Vassiliki Bruyns, Ingrid Scott, Julia Gudmundsdottir, Gudbjorg Browall, Maria Madsen, Elin Ozden, Gulten Magri, Miriam Selvekerova, Sarka Platin, Nurgun Kearney, Nora Patiraki, Elisabeth |
Contact Email: | nora.kearney@stir.ac.uk |
Keywords: | Haematologic cancers myeloma lymphoma Cancer Alternative treatment Alternative Medicine methods Blood cells Examination Oncology |
Issue Date: | May-2005 |
Date Deposited: | 2-Jun-2009 |
Citation: | Molassiotis A, Margulies A, Fernandez-Ortega P, Pud D, Panteli V, Bruyns I, Scott J, Gudmundsdottir G, Browall M, Madsen E, Ozden G, Magri M, Selvekerova S, Platin N, Kearney N & Patiraki E (2005) Complementary and alternative medicine use in patients with haematological malignancies in Europe. Complementary Therapies in Clinical Practice, 11 (2), pp. 105-110. https://doi.org/10.1016/j.ctcp.2004.12.005 |
Abstract: | Summary This study reports upon a descriptive cross-sectional survey assessing the use of complementary and alternative medicine (CAM) in patients with haematological cancers. Twelve European countries contributed data from patients with haematological cancers, as part of a larger study. Sixty-eight patients with haematological cancer participated. Among the participants, 26.5% used some form of CAM after the cancer diagnosis. The most common therapies used were homeopathy (38.9%), herbal medicine (22.2%) various psychic therapies, such as use of mediums, healers, rebirthing or past life regression therapy (22.2%). A particular profile of a CAM user was not evident in the sample. Moderate levels of satisfaction with CAM were reported. Patients commonly used CAM to increase the ability of their body to fight cancer and to improve physical and emotional wellbeing. Information about CAM was received mainly from friends or family. As CAM use in patients with haematological malignancies is common, clinicians should assist patients who want to use CAM to make an appropriate decision, and improve communication with them about CAM use in an open and non-judgemental dialogue. |
DOI Link: | 10.1016/j.ctcp.2004.12.005 |
Rights: | The publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author; you can only request a copy if you wish to use this work for your own research or private study. |
Licence URL(s): | http://www.rioxx.net/licenses/under-embargo-all-rights-reserved |
File | Description | Size | Format | |
---|---|---|---|---|
Molassiotis - Complementary and alternative medicine use in patients with haematological malignancies in Europe.pdf | Fulltext - Published Version | 178.88 kB | Adobe PDF | Under Embargo until 3000-01-01 Request a copy |
Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependent on the depositor still being contactable at their original email address.
This item is protected by original copyright |
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/
If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.